Brief: Gain Receives Notice Of Finance Chief Evan Ballantyne's Resignation

Gain Therapeutics

22/02/2024 14:33

Feb 22 (Reuters) - Gain Therapeutics Inc  GANX.O :
    * GAIN - ON FEB 19, 2024, CO RECEIVED NOTICE OF RESIGNATION
OF C.
EVAN BALLANTYNE AS CFO, ALL OTHER POSITIONS HELD AT CO, TO BE
EFFECTIVE MARCH 1, 2024
    * GAIN THERAPEUTICS INC - HAS INITIATED A SEARCH TO IDENTIFY
ITS
NEXT CHIEF FINANCIAL OFFICER

Source text for Eikon:  ID:n0001104659-24-026302 
Further company coverage:  GANX.O 

 ((Reuters.Briefs@thomsonreuters.com;))